@5_utr : SENOMAC: cT1-T3 breast cancer w/ 1-2 SLN macrometastases -> SLN only vs completion ALND RT in 950% HR for recurrence or death of 0.89 (95% CI, 0.66 to 1.19) - favoring SLN only! More data for AxRT #radonc and omission of ALND! nejm.org/doi/full/10.10… • TwiCopy

M. Bolton

@5_utr

+ Follow

ID: 1361895014935199745

calendar_today17-02-2021 04:27:47

18,18K Tweet

1,1K Followers

334 Following

M. Bolton

@5_utr

6 months ago

SENOMAC: cT1-T3 breast cancer w/ 1-2 SLN macrometastases -> SLN only vs completion ALND RT in 90% HR for recurrence or death of 0.89 (95% CI, 0.66 to 1.19) - favoring SLN only! More data for AxRT #radonc and omission of ALND! nejm.org/doi/full/10.10…